// App-Quantinova.ai

467 : YH38560, a novel bispecific fusion protein targeting 5T4 and CD47 in a tumor-selective manner for the treatment of solid cancers

Researchers

Presenter

  • Narae Lee

Principal Investigators

  • Eunjeong Jeong

  • Jung-Hoon Pyun

  • Minji Choi

  • Young Bong Park

  • Yoon ha Hwang

  • Eunjung Lee

  • Junhwan Kim

  • Se-Woong Oh

Medical Centers

  • Yuhan Corporation, Yongin, Korea (the Republic of)

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 47

  • Programmed death-ligand 1

  • Red Blood Cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved